Application of mesenchymal stem cells in regenerative medicine: A new approach in modern medical science
Mesenchymal Stem Cells (MSCs) are non‐hematopoietic and multipotent stem cells, which have been considered in regenerative medicine. These cells are easily separated from different sources, such as bone marrow (BM), umbilical cord (UC), adipose tissue (AT), and etc. MSCs have the differentiation cap...
Gespeichert in:
Veröffentlicht in: | Biotechnology progress 2023-11, Vol.39 (6), p.e3374-n/a |
---|---|
Hauptverfasser: | , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | n/a |
---|---|
container_issue | 6 |
container_start_page | e3374 |
container_title | Biotechnology progress |
container_volume | 39 |
creator | Ebrahimi, Faezeh Pirouzmand, Farzaneh Cosme Pecho, Renzon Daniel Alwan, Mariam Yassen Mohamed, Mohammed Ali, Mohammed Shnain Hormozi, Arezoo Hasanzadeh, Sajedeh Daei, Narges Hajimortezayi, Zahra Zamani, Majid |
description | Mesenchymal Stem Cells (MSCs) are non‐hematopoietic and multipotent stem cells, which have been considered in regenerative medicine. These cells are easily separated from different sources, such as bone marrow (BM), umbilical cord (UC), adipose tissue (AT), and etc. MSCs have the differentiation capability into chondrocytes, osteocytes, and adipocytes; This differentiation potential along with the paracrine properties have made them a key choice for tissue repair. MSCs also have various advantages over other stem cells, which is why they have been extensively studied in recent years. The effectiveness of MSCs‐based therapies depend on several factors, including differentiation status at the time of use, concentration per injection, delivery method, the used vehicle, and the nature and extent of the damage. Although, MSCs have emerged promising sources for regenerative medicine, there are potential risks regarding their safety in their clinical use, including tumorigenesis, lack of availability, aging, and sensitivity to toxic environments. In this study, we aimed to discuss how MSCs may be useful in treating defects and diseases. To this aim, we will review recent advances of MSCs action mechanisms in regenerative medicine, as well as the most recent clinical trials. We will also have a brief overview of MSCs resources, differences between their sources, culture conditions, extraction methods, and clinical application of MSCs in various fields of regenerative medicine. |
doi_str_mv | 10.1002/btpr.3374 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2838645561</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2838645561</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3534-90d9b58aa7cb4b943c0decd695244819b12cbd1e8f38a4a5d0e15a01368197923</originalsourceid><addsrcrecordid>eNp10E1PGzEQBmCratWkoYf-AWSpl3JY4s9dm1uKaEGKBELp2fJ6J8Ro17vYSaP8-3ob4IDEaQ7z6NXMi9A3Ss4pIWxeb4d4znklPqAplYwUJeH8I5qqSpZFpbmaoC8pPRJCFCnZZzTJVAouxBRtFsPQeme3vg-4X-MOEgS3OXS2xWkLHXbQtgn7gCM8QICY5V_IrPHOB7jACxxgj-0wxN66zQi7voEYjmRMcT4nwgn6tLZtgq_Pc4b-_LpaXV4Xy9vfN5eLZeG45KLQpNG1VNZWrha1FtyRBlxTasmEUFTXlLm6oaDWXFlhZUOASksoL_Oy0ozP0I9jbj7oaQdpazqfxidsgH6XDFNclULKkmb6_Q197Hcx5OsM00STiimpszo7Khf7lCKszRB9Z-PBUGLG-s1Yvxnrz_b0OXFX5_9f5UvfGcyPYO9bOLyfZH6u7u7_R_4DJlKPIQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2909072859</pqid></control><display><type>article</type><title>Application of mesenchymal stem cells in regenerative medicine: A new approach in modern medical science</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Ebrahimi, Faezeh ; Pirouzmand, Farzaneh ; Cosme Pecho, Renzon Daniel ; Alwan, Mariam ; Yassen Mohamed, Mohammed ; Ali, Mohammed Shnain ; Hormozi, Arezoo ; Hasanzadeh, Sajedeh ; Daei, Narges ; Hajimortezayi, Zahra ; Zamani, Majid</creator><creatorcontrib>Ebrahimi, Faezeh ; Pirouzmand, Farzaneh ; Cosme Pecho, Renzon Daniel ; Alwan, Mariam ; Yassen Mohamed, Mohammed ; Ali, Mohammed Shnain ; Hormozi, Arezoo ; Hasanzadeh, Sajedeh ; Daei, Narges ; Hajimortezayi, Zahra ; Zamani, Majid</creatorcontrib><description>Mesenchymal Stem Cells (MSCs) are non‐hematopoietic and multipotent stem cells, which have been considered in regenerative medicine. These cells are easily separated from different sources, such as bone marrow (BM), umbilical cord (UC), adipose tissue (AT), and etc. MSCs have the differentiation capability into chondrocytes, osteocytes, and adipocytes; This differentiation potential along with the paracrine properties have made them a key choice for tissue repair. MSCs also have various advantages over other stem cells, which is why they have been extensively studied in recent years. The effectiveness of MSCs‐based therapies depend on several factors, including differentiation status at the time of use, concentration per injection, delivery method, the used vehicle, and the nature and extent of the damage. Although, MSCs have emerged promising sources for regenerative medicine, there are potential risks regarding their safety in their clinical use, including tumorigenesis, lack of availability, aging, and sensitivity to toxic environments. In this study, we aimed to discuss how MSCs may be useful in treating defects and diseases. To this aim, we will review recent advances of MSCs action mechanisms in regenerative medicine, as well as the most recent clinical trials. We will also have a brief overview of MSCs resources, differences between their sources, culture conditions, extraction methods, and clinical application of MSCs in various fields of regenerative medicine.</description><identifier>ISSN: 8756-7938</identifier><identifier>EISSN: 1520-6033</identifier><identifier>DOI: 10.1002/btpr.3374</identifier><identifier>PMID: 37454344</identifier><language>eng</language><publisher>Hoboken, USA: John Wiley & Sons, Inc</publisher><subject>Adipocytes ; Adipose Tissue ; Bone marrow ; Cell culture ; Cell Differentiation ; cell therapy ; Chondrocytes ; Chondrogenesis ; Clinical trials ; Differentiation ; Medical science ; mesenchymal stem cell ; Mesenchymal Stem Cells ; Osteocytes ; Paracrine signalling ; Regenerative medicine ; Regenerative Medicine - methods ; self‐renewal ; Stem cells ; Time of use ; Tissue engineering ; tissue repair ; Tumorigenesis ; Umbilical Cord</subject><ispartof>Biotechnology progress, 2023-11, Vol.39 (6), p.e3374-n/a</ispartof><rights>2023 American Institute of Chemical Engineers.</rights><rights>2023 American Institute of Chemical Engineers</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3534-90d9b58aa7cb4b943c0decd695244819b12cbd1e8f38a4a5d0e15a01368197923</citedby><cites>FETCH-LOGICAL-c3534-90d9b58aa7cb4b943c0decd695244819b12cbd1e8f38a4a5d0e15a01368197923</cites><orcidid>0000-0002-7260-2348</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fbtpr.3374$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fbtpr.3374$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37454344$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ebrahimi, Faezeh</creatorcontrib><creatorcontrib>Pirouzmand, Farzaneh</creatorcontrib><creatorcontrib>Cosme Pecho, Renzon Daniel</creatorcontrib><creatorcontrib>Alwan, Mariam</creatorcontrib><creatorcontrib>Yassen Mohamed, Mohammed</creatorcontrib><creatorcontrib>Ali, Mohammed Shnain</creatorcontrib><creatorcontrib>Hormozi, Arezoo</creatorcontrib><creatorcontrib>Hasanzadeh, Sajedeh</creatorcontrib><creatorcontrib>Daei, Narges</creatorcontrib><creatorcontrib>Hajimortezayi, Zahra</creatorcontrib><creatorcontrib>Zamani, Majid</creatorcontrib><title>Application of mesenchymal stem cells in regenerative medicine: A new approach in modern medical science</title><title>Biotechnology progress</title><addtitle>Biotechnol Prog</addtitle><description>Mesenchymal Stem Cells (MSCs) are non‐hematopoietic and multipotent stem cells, which have been considered in regenerative medicine. These cells are easily separated from different sources, such as bone marrow (BM), umbilical cord (UC), adipose tissue (AT), and etc. MSCs have the differentiation capability into chondrocytes, osteocytes, and adipocytes; This differentiation potential along with the paracrine properties have made them a key choice for tissue repair. MSCs also have various advantages over other stem cells, which is why they have been extensively studied in recent years. The effectiveness of MSCs‐based therapies depend on several factors, including differentiation status at the time of use, concentration per injection, delivery method, the used vehicle, and the nature and extent of the damage. Although, MSCs have emerged promising sources for regenerative medicine, there are potential risks regarding their safety in their clinical use, including tumorigenesis, lack of availability, aging, and sensitivity to toxic environments. In this study, we aimed to discuss how MSCs may be useful in treating defects and diseases. To this aim, we will review recent advances of MSCs action mechanisms in regenerative medicine, as well as the most recent clinical trials. We will also have a brief overview of MSCs resources, differences between their sources, culture conditions, extraction methods, and clinical application of MSCs in various fields of regenerative medicine.</description><subject>Adipocytes</subject><subject>Adipose Tissue</subject><subject>Bone marrow</subject><subject>Cell culture</subject><subject>Cell Differentiation</subject><subject>cell therapy</subject><subject>Chondrocytes</subject><subject>Chondrogenesis</subject><subject>Clinical trials</subject><subject>Differentiation</subject><subject>Medical science</subject><subject>mesenchymal stem cell</subject><subject>Mesenchymal Stem Cells</subject><subject>Osteocytes</subject><subject>Paracrine signalling</subject><subject>Regenerative medicine</subject><subject>Regenerative Medicine - methods</subject><subject>self‐renewal</subject><subject>Stem cells</subject><subject>Time of use</subject><subject>Tissue engineering</subject><subject>tissue repair</subject><subject>Tumorigenesis</subject><subject>Umbilical Cord</subject><issn>8756-7938</issn><issn>1520-6033</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp10E1PGzEQBmCratWkoYf-AWSpl3JY4s9dm1uKaEGKBELp2fJ6J8Ro17vYSaP8-3ob4IDEaQ7z6NXMi9A3Ss4pIWxeb4d4znklPqAplYwUJeH8I5qqSpZFpbmaoC8pPRJCFCnZZzTJVAouxBRtFsPQeme3vg-4X-MOEgS3OXS2xWkLHXbQtgn7gCM8QICY5V_IrPHOB7jACxxgj-0wxN66zQi7voEYjmRMcT4nwgn6tLZtgq_Pc4b-_LpaXV4Xy9vfN5eLZeG45KLQpNG1VNZWrha1FtyRBlxTasmEUFTXlLm6oaDWXFlhZUOASksoL_Oy0ozP0I9jbj7oaQdpazqfxidsgH6XDFNclULKkmb6_Q197Hcx5OsM00STiimpszo7Khf7lCKszRB9Z-PBUGLG-s1Yvxnrz_b0OXFX5_9f5UvfGcyPYO9bOLyfZH6u7u7_R_4DJlKPIQ</recordid><startdate>202311</startdate><enddate>202311</enddate><creator>Ebrahimi, Faezeh</creator><creator>Pirouzmand, Farzaneh</creator><creator>Cosme Pecho, Renzon Daniel</creator><creator>Alwan, Mariam</creator><creator>Yassen Mohamed, Mohammed</creator><creator>Ali, Mohammed Shnain</creator><creator>Hormozi, Arezoo</creator><creator>Hasanzadeh, Sajedeh</creator><creator>Daei, Narges</creator><creator>Hajimortezayi, Zahra</creator><creator>Zamani, Majid</creator><general>John Wiley & Sons, Inc</general><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QL</scope><scope>7QO</scope><scope>7T7</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>M7N</scope><scope>P64</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-7260-2348</orcidid></search><sort><creationdate>202311</creationdate><title>Application of mesenchymal stem cells in regenerative medicine: A new approach in modern medical science</title><author>Ebrahimi, Faezeh ; Pirouzmand, Farzaneh ; Cosme Pecho, Renzon Daniel ; Alwan, Mariam ; Yassen Mohamed, Mohammed ; Ali, Mohammed Shnain ; Hormozi, Arezoo ; Hasanzadeh, Sajedeh ; Daei, Narges ; Hajimortezayi, Zahra ; Zamani, Majid</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3534-90d9b58aa7cb4b943c0decd695244819b12cbd1e8f38a4a5d0e15a01368197923</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Adipocytes</topic><topic>Adipose Tissue</topic><topic>Bone marrow</topic><topic>Cell culture</topic><topic>Cell Differentiation</topic><topic>cell therapy</topic><topic>Chondrocytes</topic><topic>Chondrogenesis</topic><topic>Clinical trials</topic><topic>Differentiation</topic><topic>Medical science</topic><topic>mesenchymal stem cell</topic><topic>Mesenchymal Stem Cells</topic><topic>Osteocytes</topic><topic>Paracrine signalling</topic><topic>Regenerative medicine</topic><topic>Regenerative Medicine - methods</topic><topic>self‐renewal</topic><topic>Stem cells</topic><topic>Time of use</topic><topic>Tissue engineering</topic><topic>tissue repair</topic><topic>Tumorigenesis</topic><topic>Umbilical Cord</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ebrahimi, Faezeh</creatorcontrib><creatorcontrib>Pirouzmand, Farzaneh</creatorcontrib><creatorcontrib>Cosme Pecho, Renzon Daniel</creatorcontrib><creatorcontrib>Alwan, Mariam</creatorcontrib><creatorcontrib>Yassen Mohamed, Mohammed</creatorcontrib><creatorcontrib>Ali, Mohammed Shnain</creatorcontrib><creatorcontrib>Hormozi, Arezoo</creatorcontrib><creatorcontrib>Hasanzadeh, Sajedeh</creatorcontrib><creatorcontrib>Daei, Narges</creatorcontrib><creatorcontrib>Hajimortezayi, Zahra</creatorcontrib><creatorcontrib>Zamani, Majid</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>Industrial and Applied Microbiology Abstracts (Microbiology A)</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Biotechnology progress</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ebrahimi, Faezeh</au><au>Pirouzmand, Farzaneh</au><au>Cosme Pecho, Renzon Daniel</au><au>Alwan, Mariam</au><au>Yassen Mohamed, Mohammed</au><au>Ali, Mohammed Shnain</au><au>Hormozi, Arezoo</au><au>Hasanzadeh, Sajedeh</au><au>Daei, Narges</au><au>Hajimortezayi, Zahra</au><au>Zamani, Majid</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Application of mesenchymal stem cells in regenerative medicine: A new approach in modern medical science</atitle><jtitle>Biotechnology progress</jtitle><addtitle>Biotechnol Prog</addtitle><date>2023-11</date><risdate>2023</risdate><volume>39</volume><issue>6</issue><spage>e3374</spage><epage>n/a</epage><pages>e3374-n/a</pages><issn>8756-7938</issn><eissn>1520-6033</eissn><abstract>Mesenchymal Stem Cells (MSCs) are non‐hematopoietic and multipotent stem cells, which have been considered in regenerative medicine. These cells are easily separated from different sources, such as bone marrow (BM), umbilical cord (UC), adipose tissue (AT), and etc. MSCs have the differentiation capability into chondrocytes, osteocytes, and adipocytes; This differentiation potential along with the paracrine properties have made them a key choice for tissue repair. MSCs also have various advantages over other stem cells, which is why they have been extensively studied in recent years. The effectiveness of MSCs‐based therapies depend on several factors, including differentiation status at the time of use, concentration per injection, delivery method, the used vehicle, and the nature and extent of the damage. Although, MSCs have emerged promising sources for regenerative medicine, there are potential risks regarding their safety in their clinical use, including tumorigenesis, lack of availability, aging, and sensitivity to toxic environments. In this study, we aimed to discuss how MSCs may be useful in treating defects and diseases. To this aim, we will review recent advances of MSCs action mechanisms in regenerative medicine, as well as the most recent clinical trials. We will also have a brief overview of MSCs resources, differences between their sources, culture conditions, extraction methods, and clinical application of MSCs in various fields of regenerative medicine.</abstract><cop>Hoboken, USA</cop><pub>John Wiley & Sons, Inc</pub><pmid>37454344</pmid><doi>10.1002/btpr.3374</doi><tpages>13</tpages><orcidid>https://orcid.org/0000-0002-7260-2348</orcidid></addata></record> |
fulltext | fulltext |
identifier | ISSN: 8756-7938 |
ispartof | Biotechnology progress, 2023-11, Vol.39 (6), p.e3374-n/a |
issn | 8756-7938 1520-6033 |
language | eng |
recordid | cdi_proquest_miscellaneous_2838645561 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Adipocytes Adipose Tissue Bone marrow Cell culture Cell Differentiation cell therapy Chondrocytes Chondrogenesis Clinical trials Differentiation Medical science mesenchymal stem cell Mesenchymal Stem Cells Osteocytes Paracrine signalling Regenerative medicine Regenerative Medicine - methods self‐renewal Stem cells Time of use Tissue engineering tissue repair Tumorigenesis Umbilical Cord |
title | Application of mesenchymal stem cells in regenerative medicine: A new approach in modern medical science |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T16%3A55%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Application%20of%20mesenchymal%20stem%20cells%20in%20regenerative%20medicine:%20A%20new%20approach%20in%20modern%20medical%20science&rft.jtitle=Biotechnology%20progress&rft.au=Ebrahimi,%20Faezeh&rft.date=2023-11&rft.volume=39&rft.issue=6&rft.spage=e3374&rft.epage=n/a&rft.pages=e3374-n/a&rft.issn=8756-7938&rft.eissn=1520-6033&rft_id=info:doi/10.1002/btpr.3374&rft_dat=%3Cproquest_cross%3E2838645561%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2909072859&rft_id=info:pmid/37454344&rfr_iscdi=true |